Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -206.41x is 1631% below its 5-year average of -11.92x, near the low end of its 5-year range (-206.41x–-2.29x).
As of the fiscal period ended Thursday, December 31, 2015.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2015 (2015-12-31): -206.41x.
INTEREST COVERAGE RATIO
-206.41x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
-60.55x
INTEREST COVERAGE RATIO AVG 5Y
-11.92x
INTEREST COVERAGE RATIO AVG 10Y
-4.21x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
-240.91%
CURRENT VS 5Y AVG
-1631.25%
CURRENT VS 10Y AVG
-4799.32%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-3105.08%
vs the sector median at left
Marker Therapeutics, Inc.
Market Cap
$16.84M
Interest Coverage Ratio
-206.41x
TTM Avg
N/A
3Y Avg
-60.55x
5Y Avg
-11.92x
Market Cap
$16.82M
Interest Coverage Ratio
-49.05x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.74M
Interest Coverage Ratio
-1288.77x
TTM Avg
51.73x
3Y Avg
51.73x
5Y Avg
51.73x
Market Cap
$16.64M
Interest Coverage Ratio
-111.88x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.52M
Interest Coverage Ratio
-15.67x
TTM Avg
0.81x
3Y Avg
0.81x
5Y Avg
0.81x
Market Cap
$17.31M
Interest Coverage Ratio
N/A
TTM Avg
15.47x
3Y Avg
15.47x
5Y Avg
15.47x
Market Cap
$17.39M
Interest Coverage Ratio
-6.31x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | $16.84M | -206.41x | N/A | -60.55x | -11.92x |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -49.05x | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -1288.77x | 51.73x | 51.73x | 51.73x |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -111.88x | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.07M | -1038.38x | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -15.67x | 0.81x | 0.81x | 0.81x |
| Lipocine Inc. (LPCN)vs › | $17.31M | N/A | 15.47x | 15.47x | 15.47x |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -6.31x | 0.97x | 0.97x | 0.97x |
| BioCardia, Inc. (BCDA)vs › | $15.78M | N/A | N/A | N/A | N/A |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -68.14x | N/A | N/A | N/A |
Interest Coverage
-206.4x
Debt/Equity
0.00
Current Ratio
6.03
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2015-12-31 | -206.41x |
| 2014-09-30 | -89.72x |
| 2014-06-30 | -59.01x |
| 2014-03-31 | -2.29x |
| 2013-12-31 | -2.52x |
| 2013-03-31 | -3.33x |
| 2012-06-30 | -31.30x |
| 2012-03-31 | -6.95x |
| 2011-12-31 | -4.05x |
| 2011-09-30 | -7.72x |
| 2011-06-30 | -7.14x |
| 2011-03-31 | -3.08x |
| 2010-12-31 | -3.76x |
| 2010-09-30 | -1.69x |
| 2010-06-30 | -6.54x |
| 2010-03-31 | -8.84x |
| 2009-12-31 | -5.70x |
| 2009-09-30 | -1.34x |
| 2009-06-30 | -7.94x |
| 2009-03-31 | -2.43x |
| 2008-12-31 | 6.81x |
| 2008-09-30 | -1.76x |
| 2008-06-30 | -1.97x |
| 2008-03-31 | -2.15x |
| 2007-12-31 | -3.83x |
| 2007-09-30 | -10.39x |
| 2006-12-31 | -26.15x |
| 2006-09-30 | -3.59x |
| 2006-06-30 | -1.61x |
| 2006-03-31 | -0.50x |
